Back to results
US 2021/0261584 A1Published application
Base-Modified Cytidine Nucleotides for Leukemia Therapy
OwnerPedro PINHO, Björn KLASSON +2inventors
InventorsPedro PINHO, Björn KLASSON, John OHD, Mark ALBERTELLA
Life of this patent
Estimating the term…
Abstract
Compounds of the formula I wherein X is a bond or —CH2, and pharmaceutically acceptable salts thereof are useful in the parenteral treatment of leukemia, myelodysplastic syndrome or lymphoma, especially in patients presenting with cytarabine resistance and/or over 60 years of age.
Claims12
A compound of the formula I
- wherein X is a bond or —CH2—
- or a pharmaceutically acceptable salt thereof.
-7. (canceled)
Dependencies are inferred from the claim text.